Astex Pharmaceuticals (ASTX)
Create an Alert
4.86
-0.02 -0.41%
NASDAQ
Jun 18, 5:00PM
BATS Real time
Currency in USD
Astex Pharmaceuticals Revenue Quarterly:
22.09M for March 31, 2013Astex Pharmaceuticals Historical Revenue Quarterly Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| March 31, 2013 | 22.09M |
| Dec. 31, 2012 | 24.06M |
| Sept. 30, 2012 | 17.19M |
| June 30, 2012 | 19.88M |
| March 31, 2012 | 22.02M |
| Dec. 31, 2011 | 21.20M |
| Sept. 30, 2011 | 16.95M |
| June 30, 2011 | 11.67M |
| March 31, 2011 | 17.10M |
| Dec. 31, 2010 | 15.28M |
| Sept. 30, 2010 | 13.38M |
| June 30, 2010 | 9.891M |
| March 31, 2010 | 14.42M |
| Dec. 31, 2009 | 11.97M |
| Sept. 30, 2009 | 10.36M |
| June 30, 2009 | 6.011M |
| March 31, 2009 | 12.91M |
| Dec. 31, 2008 | 11.94M |
| Sept. 30, 2008 | 10.21M |
| June 30, 2008 | 8.133M |
| March 31, 2008 | Go Pro |
| Dec. 31, 2007 | Go Pro |
| Sept. 30, 2007 | Go Pro |
| June 30, 2007 | Go Pro |
| March 31, 2007 | Go Pro |
| Dec. 31, 2006 | Go Pro |
| Sept. 30, 2006 | Go Pro |
| June 30, 2006 | Go Pro |
| March 31, 2006 | Go Pro |
| Dec. 31, 2005 | Go Pro |
| Sept. 30, 2005 | Go Pro |
| June 30, 2005 | Go Pro |
| March 31, 2005 | Go Pro |
| Dec. 31, 2004 | Go Pro |
| Sept. 30, 2004 | Go Pro |
| June 30, 2004 | Go Pro |
| March 31, 2004 | Go Pro |
| Dec. 31, 2003 | Go Pro |
| Sept. 30, 2003 | Go Pro |
| June 30, 2003 | Go Pro |
| March 31, 2003 | Go Pro |
| Dec. 31, 2002 | Go Pro |
| Sept. 30, 2002 | Go Pro |
| June 30, 2002 | Go Pro |
| March 31, 2002 | Go Pro |
| Dec. 31, 2001 | Go Pro |
| Sept. 30, 2001 | Go Pro |
| June 30, 2001 | Go Pro |
| March 31, 2001 | Go Pro |
| Dec. 31, 2000 | Go Pro |
About Revenues
Income that a company gains from business activities, calculated before any expenses are subtracted. Includes all sales and other increases in owner's equity. Increasing revenues over time are generally a good sign of company's growth.
While a bit obvious, if a lemonade company has sold 30 million in revenue and has 10 million in costs of goods sold, the company's revenue is still 30 million. (Expenses are not accounted in Revenue).
Learn More
ASTX Revenue Quarterly Benchmarks
| Companies | |
|---|---|
| Merck | 10.67B |
| AstraZeneca | 6.385B |
| GlaxoSmithKline | 9.834B |
ASTX Revenue Quarterly Rankings
| Overall |
67th percentile 5526 of 16773 |
| Sector |
74th percentile 361 of 1408 in Healthcare |
| Industry |
73rd percentile 36 of 135 in Drug Manufacturers - Major |
ASTX Revenue Quarterly Range, Past 5 Years
| Minimum | 6.011M | Jun 2009 |
| Maximum | 24.06M | Dec 2012 |
| Average | 14.83M |
